(Reuters) -Malaysia’s Top Glove said on Friday its quarterly profit had been nearly wiped out, adding that it expected the business environment in the immediate term to be challenging.
The world’s largest medical glove maker posted net profit of 185.7 million ringgit ($44.04 million) during the September-November quarter, a plunge of 92% from 2.36 billion ringgit a year ago.
Revenue tumbled 67% to 1.58 billion ringgit, its stock exchange filing showed.
The company said average selling prices and demand have been returning to normal after the global rollout of coronavirus vaccine, while customers stay cautious on replenishment orders, in expectation of a further fall in glove prices.
“The group saw a decrease in sales volume in the current quarter, which was attributed to increased competition and supply, owing to expansion by existing players and entrance of new players,” Top Glove said.
It added that it had gradually regained exports to the United States, and expected sales volume to improve in coming quarters.
Last year, the U.S. Customs banned imports of Top Glove’s products from Malaysia over accusations of forced labour https://www.reuters.com/world/asia-pacific/us-seizes-shipment-malaysias-top-glove-over-forced-labour-concerns-2021-05-13 at its operations, but lifted the ban in September https://www.reuters.com/business/malaysias-top-glove-says-cleared-resume-business-with-us-2021-09-10 after a review showed Top Glove addressed all indicators of forced labour.
($1=4.2170 ringgit)
(Reporting by Sayantani Ghosh in Singapore and Liz Lee in Kuala Lumpur; Editing by Clarence Fernandez)
